|
|
|
|
| LEADER |
02659nam a22003855i 4500 |
| 001 |
978-0-387-31047-3 |
| 005 |
20191026071700.0 |
| 007 |
cr nn 008mamaa |
| 008 |
100301s2006 xxu| s |||| 0|eng d |
| 020 |
|
|
|a 9780387310473
|
| 024 |
7 |
|
|a 10.1007/978-0-387-31047-3
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a New Concepts of Antiviral Therapy
|c edited by Elke Bogner, Andreas Holzenburg.
|
| 250 |
|
|
|a 1st ed. 2006.
|
| 260 |
# |
# |
|a New York, NY :
|b Springer US :
|b Imprint: Springer,
|c 2006.
|
| 300 |
|
|
|a XX, 538 p.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 505 |
0 |
|
|a Concepts of therapy for RNA viruses -- Therapeutic vaccination in chronic hepadnavirus infection -- Characterization of targets for antiviral therapy of Flaviviridae infections -- Inhibition of Hepatitis C virus by nucleic acid-based antiviral approaches -- Inhibitors of respiratory viruses -- Anti-viral approaches against influenza viruses -- A new approach to an Influenza virus live vaccine: Modification of eleavage site of the haemagglu reverse genetics -- New concepts in anti-HIV therapies -- Evaluation of current strategies to inhibit HIV entry, integration and maturation -- Managing antiretroviral resistance -- Concepts of therapy for DNA viruses -- Selective inhibitors of the replication of poxviruses -- Maribavir: A promising new antiherpes therapeutic agent -- Benzimidazole-D-ribonucleosides as antiviral agents that target HCMV terminase -- Recent developments in anti-herpesviral therapy based on protein kinase inhibitors -- Immune therapy against papillomavirus-related tumors in humans -- Concepts of therapy for emerging viruses -- The SARS Coronavirus receptor ACE 2 A potential target for antiviral therapy -- Therapy of Ebola and Marburg virus infections -- General concepts of therapy -- Proteasome inhibitors as complementary or alternative antiviral therapeutics -- Human monoclonal antibodies for prophylaxis and therapy of viral infections -- Vector-based antiviral therapy.
|
| 650 |
|
0 |
|a Virology.
|
| 650 |
|
0 |
|a Medical microbiology.
|
| 650 |
|
0 |
|a Pharmacology.
|
| 650 |
|
0 |
|a Microbiology.
|
| 650 |
|
0 |
|a Medical biochemistry.
|
| 650 |
1 |
4 |
|a Virology.
|
| 650 |
2 |
4 |
|a Medical Microbiology.
|
| 650 |
2 |
4 |
|a Pharmacology/Toxicology.
|
| 650 |
2 |
4 |
|a Microbiology.
|
| 650 |
2 |
4 |
|a Medical Biochemistry.
|
| 700 |
1 |
|
|a Bogner, Elke.
|e editor.
|
| 700 |
1 |
|
|a Holzenburg, Andreas.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-0-387-31047-3
|